Association Between the Immune System Response and Body Mass Index Among Hepatitis C Virus Saudi Patients

Osama H. Al-Jiffri 1 *
More Detail
1 Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Saudi Arabia
* Corresponding Author
EUR J BASIC MED SCI, Volume 5, Issue 4, pp. 61-66. https://doi.org/10.21601/ejbms/9174
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

Recently, about 2.35% of the world population, are estimated to be chronically infected with hepatitis C virus (HCV). However, the role of immune system dysfunction happening in state of obesity among HCV is poorly understood. The purpose of this study was to determine the strength of the association between the human immune response and body mass index (BMI) and whether differences exist in the effects of obesity on selected immune parameters among HCV Saudi patients. Two hundred non-hypertensive, non-cirrhotic Saudi patients with chronic HCV infection; Patients were divided in to two equal groups according to their body mass index : Group (A): Included HCV patients with a BMI more than 25 kg/m2 (the obese group). Group (B): Included HCV patients with a BMI between 18.5 and 23 kg/m2 (the normal-weight group). Parameters CD3, CD4 and CD8 were quantified. Leukocyte and differential counts were performed. We observed elevation with regard to the normal weight group in the parameters of white blood cells, neutrophils, monocytes, CD3, CD4 and CD8 for group A. CD3, CD4 and CD8 correlated with BMI only as a total amount, as well as with all measured parameters of blood count. There is a strong association between BMI and the human immune system among HCV patients.
Keywords: immune system, obesity, body mass index, Hepatitis C virus infection

CITATION

Al-Jiffri OH. Association Between the Immune System Response and Body Mass Index Among Hepatitis C Virus Saudi Patients. Eur J Basic Med Sci. 2015;5(4):61-6. https://doi.org/10.21601/ejbms/9174

REFERENCES

  • Rosen H. Clinical practice. Chronic hepatitis C infection. N Engl J Med 2011; 364:2429–38.
  • Sheridan D, Neely R, Bassendine M. Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs). Clinics and Research in Hepatology and Gastroenterology 2013;37:10-16.
  • European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. Journal of Hepatology 2014; 60:392–420.
  • Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2015;5:215–29.
  • Barnes E, Lauer G, Walker B, Klenerman P. T cell failure in hepatitis C virus infection; Viral Immunol 2002;15: 285–93.
  • Penna A, Missale G, Lamonaca V, PilliM C, Mori C, Zanelli P. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology 2002;35:1225–36.
  • Rico M, Quiroga J, Subira D, Garcia E, Castanon S, Sallberg M. Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. J Hepatol 2002;36:408–16.
  • Marti A, Marcos A Martinez J. Obesity and immune function relationships. Obes Rev 2001;2:131-40.
  • Karlsson E, Beck M. The burden of obesity on infectious disease. Exp Biol Med 2010; 235:1412-24.
  • Serrano P, Khuder S , Fath J. Obesity as a risk factor for nosocomial infections in trauma patients. J Am Coll Surg 2010; 211:61-67.
  • Edmonds R, Cuschieri J, Minei J, Rosengart M, Maier R. Body adipose content is independently associated with a higher risk of organ failure and nosocomial infection in the non-obese patient post-injury. J Trauma 2011;70:292-298.
  • Bochicchio G, Joshi M, Bochicchio K, Nehman S, Tracy J. Impact of obesity in the critically ill trauma patient: a prospective study. J Am Coll Surg 2006;203 :533-538.
  • Renehan A, Tyson M, Egger M, Heller R, Zwahlen M. Bodymass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lance 2008;371:569–78.
  • Nieman D, Henson D, Nehlsen-Cannarella S, Ekkens M, Utter A. Influence of obesity on immune function. J Am Diet Assoc 1999;99:294-299.
  • O‘Rourke R, Kay T, Scholz M, Diggs B, Jobe B. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg 2005;15:1463-1468.
  • Han S, Jeon K, Kim M, Kim H, Lee A. Obesity with a body mass index under 30 does not significantly impair the immune response in young adults. Nutrition Research 2011;31:362–369.
  • Lo Iacono O, Venezia G, Petta S, Mineo C, De Lisi S. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther 2007;25:1181-1191.
  • Delgado-Borrego A, Healey D, Negre B, Christofi M, Sabharwal S. Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr 2010;51:191-197.
  • Moulin C, Marguti I , Peron J, Rizzo L, Halpern A. Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metab 2009;53:183–9.
  • Womack J, Tien P, Feldman J. Obesity and immune cell counts in women. Metabolism 2007;56:998-1004.
  • Iyer A, Fairlie D, Prins J, Hammock B, Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 2010; 6:71–82.
  • Stofkova A. Leptine and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009;43:157–68.
  • Karalis K, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T .Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBSJ 2009;276: 5747–54.
  • Ilavska S, Hor آthova M, Szabova M, Nemessnyi T, Jahnova E, Tulinska J, Liskova A, Wsolova L, Staruchova M, Volkovova K. Association between the human immune response and body mass index. Human Immunology 2012;73:480–485.
  • Trischitta V, Brunetti A, Chiavetta A , Benzi L, Papa V. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes 1989; 38:1579-1584.
  • Maciver N, Jacobs S, Wieman H, Wofford J, Coloff J. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008;84:949-957.
  • Chandra R , Kutty K. Immunocompetence in obesity. Acta Paediatr Scand 1980; 69:25-30.
  • Moriguchi S, Kato M, Sakai K, Yamamoto S, Shimizu E. Decreased mitogen response of splenic lymphocytes in obese Zucker rats is associated with the decreased expression of glucose transporter 1 (GLUT-1). Am J Clin Nutr 1998;67 :1124-9.
  • Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M , Wabitsch M .T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1304–10.
  • Antuna-Puente B, Feve B, Fellahi S, Bastard J. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008;34:2–11.